Thu. 09/27
Session T.7 / KMS Chamber musichall / 02.00 - 03.30 pm
Experimental Apheresis
Chairman 1: B. Stegmayr, Umea, Sweden / Chairman 2: A. Sikole, Skopje, Macedonia
| 02.00 - 02.15 pm | O35 | Mediator modulation from whole blood or monocytic cells stimulated with lipopolysaccharide reduces enothelial activation V. Weber, Krems, Austria |
| 02.15 - 02.30 pm | O36 | A safe protocol for regional citrate anticoagulation in membrane plasma exchange S. Buettner, Frankfurt a.M., Germany |
| 02.30 - 02.45 pm | O37 | SCUF (slow continuous ultrafiltration) in the treatment of patients with cardiorenal syndrome - a single center experience W. Ries, Flensburg, Germany |
| 02.45 - 03.00 pm | O38 | Application of an extracorporeal system in non-anaesthetized rats to proof different apheresis technologies in disease models S. Berg, Karlsburg, Germany |
| 03.00 - 03.15 pm | O39 | The use of adsorbent technology in the treatment of SIRS/sepsis: A rodent model E. Coutts, Glasgow, UK |
| 03.15 - 03.30 pm | O40 | Experience with a cytokine adsorption filter in a porcine model of cardiopulmonary bypass L. Shedden, Glasgow, UK |